# Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.

> **NCT03325296** · PHASE2 · TERMINATED · sponsor: **LEO Pharma** · enrollment: 13 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** LEO 124249
- **OTHER:** Ointment vehicle

## Key facts

- **NCT ID:** NCT03325296
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-30
- **Primary completion:** 2018-05-16
- **Final completion:** 2018-05-16
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03325296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03325296, "Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03325296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*